Medibank Private (ASX:MPL) share price dips despite 27% profit boost

The Medibank Private Limited (ASX:MPL) share price is down today, despite the release of strong half-yearly results for FY20 from the insurer.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Medibank Private Ltd (ASX: MPL) shares are under pressure today following the release of the insurer's half-yearly results for FY21.

At the time of writing, the Medibank share price has dipped to $2.83, down 2.08%.

ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,

Image source: Getty Images

What did Medibank announce today?

The private health insurance provider announced a net profit after tax of $226.4 million for the 6 months ending 31 December 2020 – a 27.3% increase compared to the prior corresponding period (pcp).

The company attributed the increased profit primarily to a net gain of 49,000 policy holders over the period. 17,600 of these new customers signed up for Medibank-branded insurance itself.

"This is the first time we have grown the Medibank brand in any 6-month period since 2013 and this trend has continued into February," the company said in a media release today.

Medibank's results stand in stark contrast to the private health insurance industry at large. According to the Australian Prudential Regulatory Authority, industry profitability was down by 2 percentage points on the pcp — driven largely by the COVID-19 pandemic.

The pandemic led many private health insurance providers, including Medibank, to postpone premium increases for 6 months. Medibank stated the postponement cost the company $109 million in revenue. Despite this, revenue from premiums did rise 0.3% to $3.3 billion.

In further good news for shareholders, net claims expenses also decreased by 0.8% compared to the pcp, or $24.1 million. Gross claims fell by 1.8%, including a $99 million COVID-related reduction in claims and risk equalisation payable for the period. Underlying claims, adjusted for COVID impacts and provision movements, rose by 2.6%.

The company announced a dividend of 5.8 cents per share fully franked.

Medibank CEO to retire

Along with today's financial announcements, Medibank Private CEO Craig Drummond announced he is retiring from the position come 30 June.

Mr Drummond made the following comments about the results release and his impending retirement.

"Pleasingly Medibank is on a clear strategic path to grow the private health insurance business at a faster rate and continue its transformation into a broader healthcare company."

"Leading Medibank through this transition has been incredibly rewarding."

The Medibank share price during Mr Drummond's tenure saw a modest decline – starting around $3 when he first started while opening this morning at $2.89. During his time, Medibank shares hit a high of $3.65 and a low of $2.33.

Future outlook

Medibank is continuing its investment in healthcare. The company also announcing an expansion of its no gap joint replacement pilot into 6 regions. The pilot is a part of the company's investment into a 'short-stay model of care' program – a long-term venture aiming to reduce hospital-related expenses for both customer and company.

As of 15 February, Medibank Private is still the leading private health insurance company in Australia with a 26.9% market share and 3.7 million customers, according to comparison site ComparingExpert.

Motley Fool contributor Marc Sidarous has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

defence personnel operating and discussing defence technology
Share Gainers

These ASX defence stocks are rallying. Is it too late to buy?

3 ASX defence stocks surge as Middle East tensions escalate.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Broker Notes

Up 41% last week, why this buy rated ASX 300 stock is tipped to leap another 69%

A leading broker forecasts more outsized gains ahead for this resurgent ASX 300 tech stock.

Read more »

Crude oil barrels rocketing.
Energy Shares

This ASX 200 energy stock just jumped 13%. Here's why

Oil stocks are going ballistic today...

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Gainers

Why Ampol, EOS, Lynas, and Woodside shares are roaring higher today

These shares are starting the week with a bang. But why?

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why Brainchip, Fortescue, Qantas, and Westpac shares are dropping today

These shares are starting the week in the red. But why?

Read more »

Three happy team mates holding the winners trophy.
Share Market News

5 of the best ASX 200 stocks to buy and hold in February revealed

These five ASX 200 stocks rocketed 17% to more than 27% in February. Here’s how.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

What are analysts saying about CAR, Wesfarmers, and Xero shares?

Let's see if they are bullish or bearish on these names.

Read more »